MUSCULAR DYSTROPHY, DUCHENNE
Clinical trials for MUSCULAR DYSTROPHY, DUCHENNE explained in plain language.
Never miss a new study
Get alerted when new MUSCULAR DYSTROPHY, DUCHENNE trials appear
Sign up with your email to follow new studies for MUSCULAR DYSTROPHY, DUCHENNE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cell therapy shows promise in slowing duchenne muscular dystrophy
Disease control OngoingThis study tests a cell therapy called deramiocel (CAP-1002) in 106 boys and young men with Duchenne muscular dystrophy (DMD), a genetic disease that weakens muscles over time. Participants receive either deramiocel or a placebo every 3 months for a year, then all can receive der…
Matched conditions: MUSCULAR DYSTROPHY, DUCHENNE
Phase: PHASE3 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
High-Dose hope: new trial aims to slow Duchenne's devastating effects
Disease control OngoingThis study tests whether higher doses of the drug eteplirsen can safely improve muscle function in 160 boys with Duchenne muscular dystrophy (DMD) who have a specific genetic mutation. Participants receive weekly infusions of eteplirsen at different doses to find the best balance…
Matched conditions: MUSCULAR DYSTROPHY, DUCHENNE
Phase: PHASE3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC